摘要 |
<p>The present invention is based on the understanding of the molecular basis of MIN in human tumours as related to a similar MIN phenotype in S. cerevisiae cells harboring mutations of yeast MMR genes. Following this paradigm, the present inventors identified the basis for CIN in human tumour cells as related to mitotic checkpoint defects.</p> |